Fresolimumab Completed Phase 2 Trials for Metastatic Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01401062Fresolimumab and Radiotherapy in Metastatic Breast Cancer